对于作者

语言编辑和作者服务

We have partnered with a number of leading author services providers to offer our authors an exclusive 10% discount on a wide range of manuscript preparation and post-publication services. This discount applies to various language editing, translation, and research communication services.了解有关作者服务的更多信息。

提交

手稿应由手稿的一位作者通过在线手稿跟踪系统提交。只能通过MTS提交电子pdf（.pdf）或word（.doc，.docx，.rtf）文件，并且没有页面限制。除作者之一以外的任何人的提交都不会被接受。提交的作者在提交和同行评审过程中对手稿负责。寻求技术帮助联系held@hindawi.com。

提交条款

Manuscripts must be submitted on the understanding that they have not been published elsewhere and are only being considered by this journal. The submitting author is responsible for ensuring that the article’s publication has been approved by all the other coauthors. It is also the submitting author’s responsibility to ensure that the article has all necessary institutional approvals. Only an acknowledgment from the editorial office officially establishes the date of receipt. Further correspondence and proofs will be sent to the author(s) before publication, unless otherwise indicated. It is a condition of submission that the authors permit editing of the manuscript for readability. All inquiries concerning the publication of accepted manuscripts should be addressed toheld@hindawi.com。所有提交的内容均受Hindawi的服务条款的约束。

同行评审

All submitted articles are subject to assessment and peer review to ensure editorial appropriateness and technical correctness. In order for an article to be accepted for publication, the assigned Editor will first consider if the manuscript meets minimum editorial standards and fits within the scope of the journal. If an article is within scope, then the Editor will ideally solicit at least two external peer reviewers (whose identities will remain anonymous to the authors) to assess the article before confirming a decision to accept. Decisions to reject are at the discretion of the Editor.

我们的研究完整性团队有时会在标准同行评审之外寻求建议，例如，对具有严重道德，安全，生物安全或社会影响的提交。在决定适当的行动之前，我们可以咨询专家和学术编辑，包括但不限于：具有特定专业知识的招聘审阅者，由其他编辑进行评估，并拒绝进一步考虑提交。

并发提交

In order to ensure sufficient diversity within the authorship of the journal, authors will be limited to having three manuscripts under review at any point in time. If an author already has three manuscripts under review in the journal, they will need to wait until the review process of at least one of these manuscripts is complete before submitting another manuscript for consideration. This policy does not apply to Editorials or other non-peer reviewed manuscript types.

Article Processing Charges

该期刊是开放访问权限。文章处理费用（APC）允许发布者立即在线向任何人提供文章，以便在出版时阅读和重复使用。

预印本

印第安人supports the deposition of manuscripts in preprint servers, and does not consider this to compromise the novelty of the results. Articles based on content previously made public only on a preprint server, institutional repository, or in a thesis will be considered. The preprint should be cited.

Article types

该期刊将考虑以下文章类型：

Research Articles

研究文章应介绍原始研究的结果。这些手稿应描述如何进行研究项目，并对项目的结果进行彻底的分析。系统评价可以作为研究文章提交。

Clinical Studies

一项临床研究介绍了在临床环境中进行的研究的方法和结果。这些研究包括对现有病例的临床试验和回顾性分析。在所有情况下，临床研究都应包括对所涉及的患者组的描述，以及对研究中使用的方法和获得的结果的彻底解释。

在发布临床试验时，印第安人旨在遵守建议国际医学杂志编辑委员会（ICMJE）的试验注册。因此，要求作者注册公共试验注册中手稿中提出的临床试验，并在摘要结束时包括试验注册号。在2005年7月1日之后发起的试验必须在开始招募之前前瞻性注册。对于2005年7月1日之前发起的试验，必须在提交之前进行登记。

Reviews

A review article provides an overview of the published literature in a particular subject area.

格式化

可以下载可选的研究文章手稿模板这里。我们建议所有手稿都包含行号，并遵循以下结构：

标题和作者资格信息

• 手稿标题
• 完整的作者名称
• 完整的机构邮寄地址
• Email addresses

Affiliations.印第安人Limited remains neutral with regard to jurisdictional claims in institutional affiliations. Responsibility for affiliations ultimately rests with the author, although Hindawi may request changes be made to countries listed in affiliations to ensure consistency across published output (for indexing and discovery reasons).

抽象的

The manuscript should contain an abstract. The abstract should be self-contained, citation-free, and should not exceed 300 words.

介绍

本节应该简洁，没有子标题。

材料和方法

The methods section should provide enough detail for others to be able to replicate the study. If you have more than one method, use subsections with relevant headings, e.g. different models, in vitro and in vivo studies, statistics, materials and reagents, etc.

印第安人期刊对方法没有空间限制。这些方法（包括协议或项目描述）和算法的详细描述也可以上传为补充信息或以前提供更多详细信息的出版物。如果使用上一篇文章的方法，则必须引用和讨论本文。如果从已发表的文章中重复使用措辞，则必须注意，例如这项研究使用了Smith等人的方法。方法描述部分复制了他们的措辞[1]。

如果在研究中引入了方法或工具，包括软件，问卷调查和量表，则应在此下获得许可，并且应说明使用许可的任何要求。如果研究中使用了现有的方法或工具，则作者负责检查许可证并获得任何必要的许可。如果需要许可，则应在材料和方法部分中包括确认许可的声明。

Publishing Protocols.我们鼓励作者描述任何方法，特别是生命科学中的基于实验室的实验，以及计算和生物信息学协议，以将其方法的详细信息上传到protocols.io。This is an Open Access website that allows researchers to record their methods in a structured way, obtain a DOI to allow easy citation of the protocol, collaborate with selected colleagues, share their protocol privately for journal peer review, and choose to make it publicly available. Once published, the protocol can be updated and cited in other articles.

你可以公开协议在发布文章之前，如果您选择的话，这不会损害文章的同行评审过程，并可能使您在提交文章之前获得有关适应或改进的方法的评论（另请参阅protocolsoys.ios.ios.ios.ioFAQ page).

Protocols in the Clinical Sciences.我们鼓励临床试验和其他临床研究的作者上传他们的研究的详细计划，该计划被伦理委员会批准为补充材料。如果有该协议的已发布版本，则也应在方法部分中引用这一点。

结果与讨论

本节可以分为小节或可以合并。

Main Text (Review only)

本节可以分为小节或可以合并。

结论

This should clearly explain the main conclusions of the article, highlighting its importance and relevance.

Data Availability

该声明应描述读者如何访问支持研究结论的数据，并清楚概述无法发布不可用数据的原因。

利益冲突

作者必须声明所有可能被认为是冲突的相关利益。作者应该解释为什么每个兴趣可能代表冲突。如果不存在冲突，作者应该说明这一点。提交作者负责宣布其利益的合着者。

资金声明

作者must state how the research and publication of their article was funded, by naming financially supporting body(s) (written out in full) followed by associated grant number(s) in square brackets (if applicable), for example: “This work was supported by the Engineering and Physical Sciences Research Council [grant numbers xxxx, yyyy]; the National Science Foundation [grant number zzzz]; and a Leverhulme Trust Research Project Grant”.

如果研究没有获得特定的资金，而是作为作者就业的一部分进行的，请命名该雇主。如果资助者参与了手稿撰写，编辑，批准或出版的决定，请宣布这一点。

Acknowledgments

All acknowledgments (if any) should be included at the very end of the manuscript before the references. Anyone who made a contribution to the research or manuscript, but who is not a listed author, should be acknowledged (with their permission).

参考

作者可以以任何样式提交其参考文献。如果被接受，这些将由印第安纳州的芝加哥风格重新格式化。作者有责任确保每个参考中的信息都是完整而准确的。所有参考文献均应按照其第一次引用的顺序连续编号。文本中的参考文献的引用应使用方括号中的数字（例如，如Smith [9]所讨论的）识别；“正如其他地方讨论的[9，10]”。所有参考文献都应在文本中引用，并将删除未列出的参考文献。

Date formatting

印第安人recommends writing dates out fully to avoid confusion with different all-numeral date styles. For example, 11/10/2018 could be 10 November 2018 or 11 October 2018 depending on the reader, therefore, the date should be written out in full. For example, the date September 1, 2018 can be used rather than 01/09/2018 or 09/01/2018.

测量单位

应使用国际单位系统（SI）简单明了地介绍测量单位。

数字的准备

在提交文章后，作者应在手稿的PDF文件中包括所有数字和表。数字和表不应在单独的文件中提交。如果接受文章，将要求作者提供图形的源文件。每个图都应在单独的电子文件中提供。所有数字均应以连续顺序在手稿中引用。应该以矢量艺术格式（Illustrator，EPS，WMF，徒手，Coreldraw，PowerPoint，Excel等）或位图格式（Photoshop，Tiff，Tiff，GIF，JPEG等）提供数字。除非出于科学原因有意将分辨率设置为较低水平，否则至少应将位图图像分辨率为300 DPI分辨率。如果位图图像具有标签，则图像和标签应嵌入单独的层中。

Maps.印第安人Limited remains neutral with regard to jurisdictional claims in published maps. For reasons of consistency, authors are requested to use accepted standard maps as the basis for map figure drawing, for example using the latest standard base-map of Map Press. Responsibility for maps rests with the author and it is their responsibility to also provide any copyright or licence information when using maps that are not owned or created by the author (e.g. Google Maps, etc.)

准备桌子

Tables should be cited consecutively in the text. Every table must have a descriptive title and if numerical measurements are given, the units should be included in the column heading. Vertical rules should not be used.

补充材料

补充材料是手稿的附加部分，例如音频文件，视频剪辑或读者可能感兴趣的数据集。作者可以通过手稿跟踪系统提交一份补充材料及其手稿文件。如果有多个文件，则可以将它们上传为.zip文件。

标题为“补充材料”的部分应在参考列表之前，并为每个补充材料文件提供简洁的描述。我们的生产团队未修改补充材料。作者有责任提供将与文章一起发布的最终补充材料文件。

Proofs

Corrected proofs must be returned to the publisher within two to three days of receipt. The publisher will do everything possible to ensure prompt publication.

版权和权限

作者retain the copyright of their manuscripts, and all Open Access articles are distributed under the terms of theCreative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. The submitting author is responsible for securing any permissions needed for the reuse of copyrighted materials included in the manuscript.

虽然本期刊中的建议和信息被认为是在媒体发布之日真实而准确的，但作者，编辑或出版商都不能接受任何可能犯的错误或遗漏的法律责任。出版商就本文所包含的材料没有任何明示或暗示的保修。

Reporting guidelines

强烈建议作者在准备和提交手稿时使用适当的报告准则，以最大程度地提高透明度和可重复性。还鼓励我们的编辑和审阅者在审核过程中使用它们。提交时应在补充文件中提供完整的清单。我们特别鼓励使用：

• 配偶for randomized controlled trials
• 趋势for non-randomized trials
• Prismafor systematic review and meta-analyses
• CARE对于案例报告
• STROBEfor observational studies
• STREGA用于遗传关联研究
• srqrfor qualitative studies
• 星用于诊断准确性研究
• ARRIVE用于动物实验

Conflicts of interest

Conflicts of interest (COIs, also known as ‘competing interests’) occur when issues outside research could be reasonably perceived to affect the neutrality or objectivity of the work or its assessment. For more information, see our publication ethics policy. Authors must declare all potential interests – whether or not they actually had an influence – in a ‘Conflicts of Interest’ section, which should explain why the interest may be a conflict. If there are none, the authors should state “The author(s) declare(s) that there is no conflict of interest regarding the publication of this article.” Submitting authors are responsible for coauthors declaring their interests. Declared conflicts of interest will be considered by the editor and reviewers and included in the published article.

作者必须宣布当前或最近的资金（包括用于文章处理费用）以及可能影响工作的其他付款，商品或服务。所有资金，无论是否冲突，都必须在“资金声明”中宣布。除作者以外的任何人的参与1）对作品的结果有兴趣；2）隶属于具有如此利益的组织；或3）必须宣布由资助者雇用或支付。
You may be asked to make certain changes to your manuscript as a result of your declaration. These requests are not an accusation of impropriety. The Editor or reviewer is helping you to protect your work against potential criticisms.
If you are in any doubt about declaring a potential conflict, remember that if it is revealed later – especially after publication – it could cause more problems than simply declaring it at the time of submission. Undeclared conflicts of interest could lead to a corrigendum or, in the most serious cases, a retraction.

国际动物学命名委员会

当出版描述新的动物分类单元名称的手稿时，欣达维的目标是遵守国际动物学命名委员会（ICZN）的要求。因此，对于包括命名新动物分类单元的所有手稿，要求作者联系国际动物学命名委员会在线注册系统Zoobank，以获取生命科学识别器（LSID）。此外，要求作者在“材料和方法”部分中插入以下文本，该小节称为“命名自然行为”：

The new names contained in this article are available under the International Code of Zoological Nomenclature. This work and the nomenclatural acts it contains have been registered in ZooBank. Zoobank Life Science Identifier (LSID) for this publication is: urn:lsid:zoobank.org:pub: XXXXXXX. The LSID registration and any associated information can be viewed in a web browser by adding the LSID to the prefix “http://zoobank.org/。”

Ethical guidelines

在任何有关人类或动物受试者的研究中，都必须观察到以下道德准则。对于任何关于人类的实验，必须根据赫尔辛基的宣言（1964）进行所有工作。描述实验工作的手稿对人类受试者有伤害的风险必须包括一条陈述，即实验是在人类受试者的理解和同意下进行的，以及负责任的道德委员会批准实验的声明。在任何动物实验的情况下，作者必须对所使用的任何麻醉或外科手术进行完整描述，并证明采取了所有可能的步骤，以避免在实验的每个阶段进行动物痛苦。

Appeals

作者may appeal if they feel that the decision to reject was based on: i) a major misunderstanding over a technical aspect of the manuscript, or ii) a failure understand the scientific advance shown by the manuscript. Appeals requesting a second opinion without sufficient justification will not be considered. To lodge an appeal, please contact the journal by email, quoting your manuscript number. Appeals will only be considered from the original submitting author.